Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
46 hedge funds and large institutions have $62.8M invested in Psychemedics Corporation in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 7 closing their positions.
8% more capital invested
Capital invested by funds: $58M → $62.8M (+$4.76M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 51 → 46 (-5)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q4 2017 in Review
46 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2017, worth a combined $62.8M — up 8.2% from $58M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PMD and 3 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 17 added.
The largest buyer was Moors & Cabot, adding an estimated $672K. The largest seller was Numeric Investors, exiting entirely with an estimated $1.49M sold.
- 46 institutional investors held Psychemedics Corporation (PMD) as of Q4 2017, down from 51 in Q3 2017.
- Funds reported $62.8M of Psychemedics Corporation stock for Q4 2017, up 8.2% quarter-over-quarter.
- 3 funds opened new Psychemedics Corporation positions in Q4 2017 and 7 closed out, a net change of -4 holders.
- The largest Psychemedics Corporation buyer in Q4 2017 was Moors & Cabot, an estimated $672K added.
- The largest Psychemedics Corporation seller in Q4 2017 was Numeric Investors, an estimated $1.49M sold.
Based on aggregated 13F filings for Q4 2017.